Nicotine Transdermal System Patch, 14 mg recall — Aveva Drug Delivery Systems, Inc. (Class III)

Regulatory snapshot

Reason reported by FDA

Failed Impurities/Degradation Specifications: Elevated levels of oxidative-related impurities, exceeding shelf-life specifications during stability testing of individual units.

17 words from the enforcement report field reason_for_recall, reproduced without edit — the firm's own wording, not an assessment.

Product identifiers in this record

6 identifying values matched by exact pattern in the 21-word product description above; each is a literal substring of it.

Reading this record

Class III is the FDA's own severity tier for the recall action — 25 of the 250 indexed records carry it — and it describes the agency's assessment of the action, not a risk statement about any individual. Match a package against 0536-5895-88 at the FDA source to confirm it is covered.

Namespace context: the Class III index (25 records) and the recall hub (250 records, 118 FDA events); Aveva Drug Delivery Systems, Inc. (1 indexed records) aggregates this firm across datasets.

• What "Ongoing" recall status means
• How to search FDA drug recalls by NDC
• FDA recall classifications: Class I, II and III
• How to read an FDA drug recall record

Coverage and limits of this record

This page reflects the openFDA enforcement report for D-0550-2026 as ingested on 2026-08-22, which can lag the live FDA record and omits detail held only in primary documents. It offers no clinical assessment, no advice about whether to use any product, and no substitute. For any health question consult a qualified healthcare professional.